SEC-sourced researchBeta

WHWK

Whitehawk Therapeutics, Inc.

US markets

Data passport

CIK: 0001422142
Exchange: Nasdaq
Business activity: — · SIC 2834
Financial inputs: 6/6
Filing date: Sep 18, 2026
SEC registry record: Operating company

Last updated: Oct 8, 2026, 9:09 AM UTCSEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Chart metric

WHWK · Exact amounts and source periods · USD
Period end	Revenue	Filing date
December 2024	25,983,000.0000	Mar 12, 2026
December 2025	7,145,000.0000	Mar 12, 2026

Annual periods · USD

Period end	Revenue	Net income	Operating cash flow	Total assets	Total liabilities	Filing date
December 2025	7,145,000.0000	-20,596,000.0000	-97,433,000.0000	150,830,000.0000	14,519,000.0000	Mar 12, 2026
December 2024	25,983,000.0000	-63,691,000.0000	-59,550,000.0000	70,319,000.0000	17,841,000.0000	Mar 12, 2026

Financial inputs behind the calculation

Financial inputs	USD	Period end	Filing date	Form
RevenueRevenueFromContractWithCustomerExcludingAssessedTax	$7.15M	December 2025	Mar 12, 2026	10-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax	$25.98M	December 2024	Mar 12, 2026	10-K
Net incomeNetIncomeLoss	-$20.6M	December 2025	Mar 12, 2026	10-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities	-$97.43M	December 2025	Mar 12, 2026	10-K
Total assetsAssets	$150.83M	December 2025	Mar 12, 2026	10-K
Total liabilitiesLiabilities	$14.52M	December 2025	Mar 12, 2026	10-K

New filings

Explore methodology ↗